Inventor
Mary STRUTHERS
Inventor
US
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C12NMicroorganisms or enzymes20%
Y02ATechnologies for adaptation to climate change5%
PatentTitleYear
12,419,953Methods of treatment or prevention of immune responses and inflammatory diseases with antagonistic CD40 monoclonal antibodies202512,409,223Antagonistic CD40 monoclonal antibodies and uses thereof202512,202,872Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use202511,926,673Antagonistic CD40 monoclonal antibodies and uses thereof202411,795,231Antagonistic CD40 monoclonal antibodies and uses thereof202311,773,178Antagonistic CD40 monoclonal antibodies and uses thereof202311,613,585Nucleic acids encoding antagonistic CD40 monoclonal antibodies202311,359,000Interleukin-2/Interleukin-2 receptor alpha fusion proteins and methods of use202211,261,258Antagonistic CD40 monoclonal antibodies and uses thereof202211,254,750Antagonistic CD40 monoclonal antibodies and uses in treating immune responses202211,220,550Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activity2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to BRISTOL MYERS SQUIBB CO (11)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 11 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 11 | 2022–2025 |